BullFrog AI's bfLEAP platform identified biomarkers linked to improved survival in pancreatic adenocarcinoma patients treated with glufosfamide. The study revealed four patient clusters, with one ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback